225 related articles for article (PubMed ID: 3133576)
1. Treatment of multiple sclerosis with various interferons: the cons.
Johnson KP
Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
[TBL] [Abstract][Full Text] [Related]
2. Systemic interferon therapy of multiple sclerosis: the pros.
Knobler RL
Neurology; 1988 Jul; 38(7 Suppl 2):58-61. PubMed ID: 3133575
[TBL] [Abstract][Full Text] [Related]
3. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
Kuzmits R; Scheithauer W; Ludwig H; Flener R
Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
[TBL] [Abstract][Full Text] [Related]
4. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
Eisenburg J; Caselmann W; Eder M; Pape GR
Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
[No Abstract] [Full Text] [Related]
5. Interferons: not just alpha.
Krown SE
Cancer Treat Rep; 1986 Dec; 70(12):1353-5. PubMed ID: 2431773
[No Abstract] [Full Text] [Related]
6. [Treatment of multiple sclerosis with interferons].
Nogales-Gaete J; Arriagada C
Rev Med Chil; 1996 May; 124(5):597-604. PubMed ID: 9035514
[TBL] [Abstract][Full Text] [Related]
7. Effects of experimental recombinant interferons on multiple sclerosis.
Johnson KP; Panitch HS
Trans Am Clin Climatol Assoc; 1989; 100():171-6. PubMed ID: 2479162
[No Abstract] [Full Text] [Related]
8. [Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results].
Huber M
Nervenarzt; 1988 Sep; 59(9):514-20. PubMed ID: 2460777
[No Abstract] [Full Text] [Related]
9. Interferons in therapeutics.
Wardle EN
Br J Hosp Med; 1989 Jan; 41(1):99. PubMed ID: 2493959
[No Abstract] [Full Text] [Related]
10. [Interferon in the treatment of multiple myeloma].
Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
[TBL] [Abstract][Full Text] [Related]
11. [Significance of neutralizing antibodies to immunomodulatory therapy and their laboratory analysis in multiple sclerosis].
Seres E; Vécsei L
Ideggyogy Sz; 2006 May; 59(5-6):156-62. PubMed ID: 16786710
[TBL] [Abstract][Full Text] [Related]
12. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
Triozzi PL; Kenney P; Young D; Rinehart JJ
Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
[No Abstract] [Full Text] [Related]
13. Interferon.
Hood LE
Am J Nurs; 1987 Apr; 87(4):459-65. PubMed ID: 2436479
[No Abstract] [Full Text] [Related]
14. Approaches to the stabilization of interferons.
Sedmak JJ; Grossberg SE
Tex Rep Biol Med; 1981-1982; 41():274-9. PubMed ID: 6817438
[TBL] [Abstract][Full Text] [Related]
15. [Behçet disease and exogenous interferon. A successful treatment study using recombinant alpha-A-IFN].
Stadler R; Bratzke B; Baumann I
Hautarzt; 1987 Feb; 38(2):97-100. PubMed ID: 3570783
[TBL] [Abstract][Full Text] [Related]
16. [Contribution of immunology to the treatment of multiple sclerosis].
Pérez-Miranda J; Parrilla-Ramírez JL
Rev Neurol; 1998 Jul; 27(155):117-21. PubMed ID: 9674043
[TBL] [Abstract][Full Text] [Related]
17. Interferon therapy for multiple sclerosis.
Johnson KP; Panitch HS
Md Med J; 1992 Jul; 41(7):601-3. PubMed ID: 1379317
[TBL] [Abstract][Full Text] [Related]
18. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
[No Abstract] [Full Text] [Related]
19. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
[TBL] [Abstract][Full Text] [Related]
20. Drug Insight: interferon treatment in multiple sclerosis.
Marrie RA; Rudick RA
Nat Clin Pract Neurol; 2006 Jan; 2(1):34-44. PubMed ID: 16932519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
